August 20, 2017 6:49 AM ET

Life Sciences Tools and Services

Company Overview of MediBIC Group

Company Overview

MediBIC Group provides healthcare and drug development services. It provides genetic testing services with diagnostic tools to doctors; GLP-compliant gene profiling services to pharmaceutical companies; and sample banking and management services, as well as focuses on providing health care services to pets. The company is also involved in developing a cell culture system; selling consumables; promoting licensing activities for the pancreatic cancer drug Glufosfamide; the research and development of pharmaceuticals and diagnostic agents, etc.; and providing data analysis for preventive health care, as well as clinical trial services to cell therapy. MediBIC Group was founded in 2000 and is he...

Rohto Tokyo Building

5th Floor

1-7-5 Shiba

Minato-Ku

Tokyo,  105-0014

Japan

Founded in 2000

17 Employees

Phone:

81 3 5439 9691

Fax:

81 3 5439 9696

Key Executives for MediBIC Group

President and Representative Director
Age: 49
Chief Financing Officer
Chief Operating Officer and Vice President
Executive Officer, General Manager of Administrative Division and Director
Age: 49
Chief Representative of Shanghai Office
Compensation as of Fiscal Year 2017.

MediBIC Group Key Developments

MediBIC Group expected to report Q2 2017 results on August 19, 2017. This event was calculated by Capital IQ (Created on August 13, 2017).

MediBIC Group expected to report Q2 2017 results on August 19, 2017. This event was calculated by Capital IQ (Created on August 13, 2017).

MediBIC Group To Be Delisted From Tokyo Stock Exchange

MediBIC Group will be delisted from Tokyo Stock Exchange, effective October 6, 2016. The delisting was due to the sales of a company is less than the required value.

MediBIC Group Reports Consolidated Earnings Results for the First Quarter Ended March 31, 2016; Provides Earnings Guidance for the Six Months Ending June 2016 and Fiscal Ending December 2016

MediBIC Group reported consolidated earnings results for the first quarter ended March 31, 2016. The company reported net sales of ¥52 million, operating loss of ¥114 million, net loss attributable to owners of parent of ¥112 million or ¥3.81 per share against net sales of ¥35 million, operating loss of ¥113 million, net loss attributable to owners of parent of ¥145 million or ¥4.98 per share a year ago. For the six months ending June 2016, the company expects net sales of ¥108 million, operating loss of ¥80 million, net loss attributable to owners of parent of ¥79 million or ¥2.72 per share. For the fiscal ending December 2016, the company expects net sales of ¥364 million, operating income of ¥5 million, net income attributable to owners of parent of ¥3 million or ¥0.12 per share.

Similar Private Companies By Industry

Company Name Region
AC Medical Inc. Asia
Anti-Aging Science Inc. Asia
AskAt Inc. Asia
Central Institute for Experimental Animals Asia
CLINICAL SUPPORT Ltd. Asia

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
The Advertising Council, Inc. United States
Bertelsmann AG Europe
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact MediBIC Group, please visit www.medibic.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.